Skip to main content
Veterinary Medicines

Versican Plus L4 (--) - Suspension for injection

Authorised
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain MSLB 1089, Inactivated
  • Leptospira interrogans, serovar Canicola, strain MSLB 1090, Inactivated
  • Leptospira kirschneri, serovar Grippotyphosa, strain MSLB 1091, Inactivated
  • Leptospira interrogans, serogroup Australis, serovar Bratislava, strain MSLB 1088, Inactivated

Product identification

Medicine name:
Versican Plus L4 (--) - Suspension for injection
Active substance:
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain MSLB 1089, Inactivated
  • Leptospira interrogans, serovar Canicola, strain MSLB 1090, Inactivated
  • Leptospira kirschneri, serovar Grippotyphosa, strain MSLB 1091, Inactivated
  • Leptospira interrogans, serogroup Australis, serovar Bratislava, strain MSLB 1088, Inactivated
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain MSLB 1089, Inactivated
    1.51
    Antibody microagglutination-lytic reaction
    /
    1.00
    Vial
  • Leptospira interrogans, serovar Canicola, strain MSLB 1090, Inactivated
    1.51
    Antibody microagglutination-lytic reaction
    /
    1.00
    Vial
  • Leptospira kirschneri, serovar Grippotyphosa, strain MSLB 1091, Inactivated
    1.40
    Antibody microagglutination-lytic reaction
    /
    1.00
    Vial
  • Leptospira interrogans, serogroup Australis, serovar Bratislava, strain MSLB 1088, Inactivated
    Presentation_strength:1:51 ALR Reference:Ph EUR 0447 Comments:Suspension Index:3
Pharmaceutical form:
  • Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AB01
Authorisation status:
  • Valid
Authorised in:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
Available in:
  • Belgium
  • Cyprus
  • Denmark
  • Greece
  • Ireland
  • Italy
  • Luxembourg
  • Netherlands
  • United Kingdom (Northern Ireland)
Package description:
  • Packaging:Vial (glass), Package_size:50 vials, Content:1 ml
  • Packaging:Vial (glass), Package_size:25 vials, Content:1 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Belgium SA
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • European Commission
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

English (PDF)
Published on: 5/03/2025
Download
Bulgarian (PDF)
Published on: 5/03/2025
Croatian (PDF)
Published on: 5/03/2025
Czech (PDF)
Published on: 5/03/2025
Danish (PDF)
Published on: 5/03/2025
Dutch (PDF)
Published on: 5/03/2025
Estonian (PDF)
Published on: 5/03/2025
Finnish (PDF)
Published on: 5/03/2025
French (PDF)
Published on: 5/03/2025
German (PDF)
Published on: 5/03/2025
Greek (PDF)
Published on: 5/03/2025
Hungarian (PDF)
Published on: 5/03/2025
Icelandic (PDF)
Published on: 5/03/2025
Italian (PDF)
Published on: 5/03/2025
Latvian (PDF)
Published on: 5/03/2025
Lithuanian (PDF)
Published on: 5/03/2025
Maltese (PDF)
Published on: 5/03/2025
Norwegian (PDF)
Published on: 5/03/2025
Polish (PDF)
Published on: 5/03/2025
Portuguese (PDF)
Published on: 5/03/2025
Romanian (PDF)
Published on: 5/03/2025
Slovak (PDF)
Published on: 5/03/2025
Slovenian (PDF)
Published on: 5/03/2025
Spanish (PDF)
Published on: 5/03/2025
Swedish (PDF)
Published on: 5/03/2025

ema-puar-versican-plus-l4-v-3680-par-en.pdf

English (PDF)
Published on: 16/03/2023
Download